title: Effect of diacerein on insulin secretion and metabolic control in drug-naive patients with type 2 diabetes: a randomized clinical trial.
abstract: OBJECTIVE
  To assess the effect of diacerein on insulin secretion and metabolic control in drug-naïve patients with type 2 diabetes.
  
  
  METHODS
  A randomized, double-blind, placebo-controlled clinical trial was carried out in 40 drug-naïve adult patients with type 2 diabetes. A metabolic profile including interleukin (IL)-1β, tumor necrosis factor-α, IL-6, and fasting insulin levels was carried out before the intervention and 2 months afterward. A hyperglycemic-hyperinsulinemic clamp technique was performed to assess the phases of insulin secretion and insulin sensitivity. After randomization, 20 patients received diacerein (50 mg once daily) for the first 15 days and twice daily for 45 additional days. The remaining patients received placebo. Intra- and intergroup differences were calculated by Wilcoxon signed rank and Mann-Whitney U tests.
  
  
  RESULTS
  There were significant increases in first (102±63 vs. 130±75 pmol/L; P<0.01), late (219±111 vs. 280±135 pmol/L; P<0.01), and total insulin (178±91 vs. 216±99 pmol/L; P<0.01) secretions without changes in insulin sensitivity after diacerein administration. There were significant decreases in fasting glucose (7.9±1.4 vs. 6.8±1.0 mmol/L; P<0.01) and in A1C levels (8.3±1.0 vs. 7.0±0.8%; P<0.001) after diacerein administration. There were no significant changes after placebo administration in the above-mentioned evaluations.
  
  
  CONCLUSIONS
  Insulin secretion increased and metabolic control improved after diacerein administration in drug-naïve patients with type 2 diabetes.
authors: Medical Research Unit in Clinical Epidemiology, Specialties Hospital, Medical Unit of High Specialty, West National Medical Center, Mexican Institute of Social Security, and Physiology Department, Health Science University Center, University of Guadalajara, Guadalajara, Mexico.
authors: Maria G
authors: MG
authors: Ramos-Zavala
authors: Manuel
authors: M
authors: González-Ortiz
authors: Esperanza
authors: E
authors: Martínez-Abundis
authors: José A
authors: JA
authors: Robles-Cervantes
authors: Roberto
authors: R
authors: González-López
authors: Nestor J
authors: NJ
authors: Santiago-Hernández
references: Arthritis Res Ther. 2008;10(3):R71
references: 18578867
references: Osteoarthritis Cartilage. 2010 Mar;18(3):289-96
references: 19857509
references: Metab Syndr Relat Disord. 2005 Summer;3(2):95-101
references: 18370716
references: Endocr Rev. 2008 May;29(3):334-50
references: 18048762
references: Diabetes Care. 2009 Sep;32(9):1663-8
references: 19542207
references: Diabetes. 2002 Jun;51(6):1772-8
references: 12031964
references: J Atheroscler Thromb. 2010 Apr 30;17(4):332-41
references: 20124732
references: Am J Physiol. 1979 Sep;237(3):E214-23
references: 382871
references: Diabetes. 2009 Apr;58(4):773-95
references: 19336687
references: Acta Diabetol. 2013 Apr;50(2):163-73
references: 21153483
references: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005117
references: 16437519
references: Indian Pediatr. 1989 Feb;26(2):115-21
references: 2753525
references: Diabetes Res Clin Pract. 2007 Jan;75(1):115-8
references: 16781793
references: Int Immunopharmacol. 2008 Jun;8(6):782-91
references: 18442781
references: N Engl J Med. 2007 Apr 12;356(15):1517-26
references: 17429083
references: Diabetes Care. 2009 Jul;32(7):1244-9
references: 19366957
references: Arch Dermatol Res. 2007 Nov;299(9):461-5
references: 17726611
references: Diabetologia. 2008 Jul;51(7):1213-25
references: 18463842
references: Rev Invest Clin. 2003 Jul-Aug;55(4):419-22
references: 14635606
references: Diabetes. 2009 Dec;58(12):2718-25
references: 19940235